In an older adult patient, should bilastine be used as a first‑line systemic antipruritic?

Should Bilastine Be Used as First-Line Systemic Antipruritic in Older Adults?

No, bilastine should not be used as first-line systemic antipruritic in older adults with generalized pruritus. The British Association of Dermatologists guidelines specifically recommend non-sedative antihistamines such as fexofenadine 180 mg or loratadine 10 mg, or mildly sedative agents such as cetirizine 10 mg for generalized pruritus of unknown origin (GPUO), but bilastine is notably absent from these recommendations 1.

Guideline-Based Approach for Elderly Patients with Pruritus

Initial Management (First-Line)

• Start with emollients and topical steroids for at least 2 weeks to exclude asteatotic eczema, which is the most common cause in elderly patients 1
• Use moisturizers with high lipid content, which are preferred in the elderly 1
• Provide self-care advice (keeping nails short, avoiding irritants) 1

Systemic Treatment (If Topical Therapy Fails)

For GPUO in elderly patients, the guidelines recommend:

• Non-sedative H1 antihistamines: fexofenadine 180 mg or loratadine 10 mg 1
• Mildly sedative option: cetirizine 10 mg (acceptable alternative) 1
• Combination therapy: H1 + H2 antagonists (e.g., fexofenadine + cimetidine) 1

Critical Safety Warning for Elderly

Sedative antihistamines should NOT be prescribed in elderly patients with pruritus (Strength of recommendation C) 1. Long-term sedative antihistamines may predispose to dementia and should be avoided except in palliative care settings 1.

Second-Line Options (If Antihistamines Fail)

If initial antihistamine therapy is inadequate, consider 1:

• Gabapentin (specifically mentioned as beneficial for elderly pruritus) 1
• Paroxetine, fluvoxamine, mirtazapine
• Naltrexone, pregabalin, ondansetron, or aprepitant

Why Not Bilastine for Elderly Pruritus?

Absence from Guidelines

The 2018 British Association of Dermatologists guidelines, which specifically address pruritus in elderly patients, do not include bilastine in their recommendations despite listing multiple antihistamine options 1. This is significant because these guidelines were published contemporaneously with bilastine's availability.

Evidence Base Limitations

While bilastine has demonstrated efficacy in:

• Chronic spontaneous urticaria 2, 3, 4, 5
• Allergic rhinoconjunctivitis 6, 7, 8, 9
• Pruritus associated with specific skin diseases 2, 10

The research evidence focuses primarily on urticaria and allergic conditions, not generalized pruritus of unknown origin in elderly patients—the specific clinical scenario in question.

Safety Profile in Elderly

Bilastine does have favorable safety data in elderly patients (≥65 years) with allergic rhinoconjunctivitis and urticaria, showing low incidence of treatment-emergent adverse events 6. It requires no dose adjustment in elderly patients or those with renal/hepatic impairment 7. However, this safety profile was established for allergic conditions, not for the broader indication of generalized pruritus.

Clinical Algorithm for Elderly Pruritus

1. Weeks 0-2: Emollients (high lipid content) + topical steroids
2. Reassess at 2 weeks: If no improvement, proceed to step 3
3. Add systemic therapy: Fexofenadine 180 mg OR loratadine 10 mg daily
4. Week 4-6: If inadequate response, consider:
   • Adding H2 antagonist (cimetidine) to H1 blocker
   • OR switching to gabapentin
5. Refer to secondary care if diagnostic doubt or symptoms persist despite primary care management 1

Common Pitfalls to Avoid

• Do not use sedating antihistamines (hydroxyzine, diphenhydramine) in elderly patients except in palliative care due to dementia risk 1
• Do not skip the initial 2-week trial of emollients and topical steroids—asteatotic eczema is extremely common in elderly patients and may be misdiagnosed as primary pruritus 1
• Do not use cetirizine for uraemic pruritus—it has been shown ineffective in this specific context 1
• Reassess patients who don't respond to initial treatment rather than continuing ineffective therapy 1

The evidence clearly supports using guideline-recommended antihistamines (fexofenadine, loratadine) over bilastine for elderly patients with generalized pruritus, with gabapentin as the preferred second-line agent when antihistamines fail.